Skip to main content
. 2018 Jul 4;16(3):3651–3657. doi: 10.3892/ol.2018.9072

Table I.

Demographics of patients.

Groups Itraconazole, n=22 Control, n=38
Median age (range) 53 (43–71) 56 (39–73)
Women, n (%) 6 (27.2) 12 (31.6)
Men, n (%) 16 (72.8) 26 (68.4)
ECOG PS, n (%)
  0 2 (9.0) 3 (7.9)
  1 17 (77.3) 30 (79)
  2 3 (13.6) 5 (13.1)
Metastasis positive, n (%) 4 (18.2) 8 (21.1)
Histological type, n (%)
  Adenocarcinoma 22 (100.0) 37 (97.3)
  Other 0 (0.0) 1 (2.7)

ECOG, Eastern Cooperative Oncology Group; PS, performance status.